Trial intelligence / Profile preview

Efficacy of Elidel Cream on Erosive Oral Lichen Planus

NCT00130572Phase 3Completed

Sponsor
University Hospital Tübingen
Start
Jun 2004
Primary completion
Dec 2007
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised trial in oral lichen planus (OLP) comparing Pimecrolimus with Placebo (2 arms). Primary endpoint: Reduction of a symptom score. Started Jun 2004; status: completed.

02

Drugs

pimecrolimus
03

Conditions

oral lichen planus (OLP)

Beyond the preview

Go deeper on NCT00130572.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00130572.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call